We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.89B
AUM Growth
+$197M
Cap. Flow
-$2.65M
Cap. Flow %
-0.09%
Top 10 Hldgs %
30.11%
Holding
781
New
94
Increased
203
Reduced
222
Closed
81
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
201
Duke Energy
DUK
$100B
$1.98M 0.07%
20,010
+1,984
+11% +$199K
AZO icon
202
AutoZone
AZO
$48B
$1.97M 0.07%
1,321
ICF icon
203
iShares Select U.S. REIT ETF
ICF
$2.09B
$1.96M 0.07%
29,938
-750
-2% -$47.1K
BIL icon
204
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
$1.94M 0.07%
21,257
SPYX icon
205
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.72B
$1.93M 0.07%
54,663
+10,170
+23% +$351K
LLY icon
206
Eli Lilly
LLY
$1.05T
$1.88M 0.07%
8,194
+181
+2% +$36.4K
AXP icon
207
American Express
AXP
$232B
$1.88M 0.06%
11,366
-100
-0.9% -$15.7K
CL icon
208
Colgate-Palmolive
CL
$72B
$1.87M 0.06%
22,962
-488
-2% -$39.9K
SUSB icon
209
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.29B
$1.85M 0.06%
71,142
-41,239
-37% -$1.07M
EXAS
210
DELISTED
Exact Sciences
EXAS
$1.85M 0.06%
14,897
-664
-4% -$79.2K
ARDX icon
211
Ardelyx
ARDX
$1.24B
$1.8M 0.06%
237,000
-116,000
-33% -$858K
REGL icon
212
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.74B
$1.79M 0.06%
25,154
+4,623
+23% +$335K
CRWD icon
213
CrowdStrike
CRWD
$187B
$1.77M 0.06%
28,196
-1,236
-4% -$66.5K
XOM icon
214
ExxonMobil
XOM
$654B
$1.76M 0.06%
27,985
-7,140
-20% -$426K
PM icon
215
Philip Morris
PM
$301B
$1.72M 0.06%
17,323
ECL icon
216
Ecolab
ECL
$74.1B
$1.7M 0.06%
8,262
+230
+3% +$50K
ZNTL icon
217
Zentalis Pharmaceuticals
ZNTL
$330M
$1.68M 0.06%
+31,500
New +$1.69M
RVMD icon
218
Revolution Medicines
RVMD
$40.6B
$1.67M 0.06%
52,500
+20,200
+63% +$705K
SO icon
219
Southern Company
SO
$108B
$1.66M 0.06%
27,462
+2,339
+9% +$150K
IEMG icon
220
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
$1.66M 0.06%
24,720
-998
-4% -$65.8K
VRDN icon
221
Viridian Therapeutics
VRDN
$2.11B
$1.66M 0.06%
90,500
-20,500
-18% -$351K
NKE icon
222
Nike
NKE
$61.2B
$1.65M 0.06%
10,700
HARP
223
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1.65M 0.06%
11,888
-1,190
-9% -$227K
VIRX
224
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.64M 0.06%
145,000
+108,000
+292% +$1.08M
INFY icon
225
Infosys
INFY
$42.4B
$1.62M 0.06%
76,557
-34,700
-31% -$663K

Similar funds

Bailard's Q2 2021 Portfolio in Review

As of Q2 2021, Bailard held 781 positions worth $2.89B, up 7.3% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bailard's Q2 2021 filing shows 94 new, 203 increased, 222 reduced and 81 closed positions. Its largest new stake was First Trust Senior Loan Fund ETF: 335,979 shares worth $16.1M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q2 2021 buy was First Trust Senior Loan Fund ETF: 335,979 shares worth $16.1M.
  • Bailard added most to Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q2 2021, an estimated $74.6M increase.
  • Bailard's biggest Q2 2021 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $72M.
  • Bailard fully exited Nice in Q2 2021, selling an estimated $2.62M.
  • Bailard's ten largest holdings make up 30% of its $2.89B portfolio in Q2 2021.
  • Bailard opened 94 new positions and closed 81 in Q2 2021.
  • Bailard's portfolio value rose 7.3% quarter-over-quarter to $2.89B.

Based on Bailard's 13F filing for Q2 2021, filed 13 Aug 2021.